Injective (INJ) is attracting growing attention from institutional investors after 21Shares filed a new ETF for the token.

Investing.com -- Cryptocurrency Injective ( INJ) now has its second exchange-traded fund in development after 21Shares filed paperwork with the Securities and Exchange Commission for an Injective ETF ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

Andriy Blokhin has 5+ years of professional experience in public accounting, personal investing, and as a senior auditor with Ernst & Young. Erika Rasure is globally-recognized as a leading consumer ...

Barbara Friedberg is a veteran investment portfolio manager, fintech consultant, and expert investor. She is a published author of several books. Suzanne is a content marketer, writer, and ...